Vifor Pharma is Galenica's top competitor. Vifor Pharma was founded in 1933 in Glattbrugg, Other. Vifor Pharma competes in the Pharmaceuticals field. Vifor Pharma generates $2.6B less revenue than Galenica.
Galenica VS Celltrion
Celltrion is perceived as one of Galenica's biggest rivals. Celltrion's headquarters is in Incheon, Gyeonggido, and was founded in 2002. Like Galenica, Celltrion also competes in the Biotechnology industry. Celltrion generates 48% of Galenica's revenue.
Galenica VS 3SBIO
3SBIO is one of Galenica's top competitors. 3SBIO is a Public company that was founded in Shenyang, Liaoning Province in 1993. Like Galenica, 3SBIO also competes in the Pharmaceuticals & Biotechnology field. 3SBIO has 2,318 fewer employees vs. Galenica.
FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye...
Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. SLXN (" Silexion " or the " Company "), a clinical-stage b...
Roche has introduced its Chest Pain Triage algorithm, which is designed to rapidly identify acute coronary syndrome (ACS). The post Roche introduces al...
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of influenza virus, from an infecte...
Roche Diagnostics Korea said it hosted its internal "navify day" on Tuesday to showcase the evolution of its digital healthcare solutions.A highlight o...
Roche's Genentech is betting on the Flagship Pioneering-founded company's discovery platform called DECODE to find new targets for an undisclosed autoi...
Frequently Asked Questions about Galenica
Who are Galenica's top competitors?
Galenica's top 3 competitors are Vifor Pharma, Celltrion, 3SBIO.
Who is similar to Galenica?
Vifor Pharma is the most similar to Galenica. Celltrion and 3SBIO are also similar to Galenica.
Are Galenica and Vifor Pharma competitors?
Yes, Vifor Pharma is one of Galenica’s top competitors.